Skip to main content
News

FDA Recalls Sevoflurane Inhalation Anesthetic


June 20, 2019

Baxter Healthcare Corporation is recalling 5940 bottles of sevoflurane inhalation anesthetic because the product failed to meet stability specifications, according to the June 19, 2019, US Food and Drug Administration (FDA) Enforcement Report.  

The recall affects 250-mL bottles (NDC 10019-651-64) from lot S110F822 (Exp. 5/31/21). The affected bottles were distributed throughout the United States. 

Baxter Healthcare Corporation voluntarily initiated the recall June 13, 2019. At press time, the FDA had not yet issued a classification for the recall. 

Sevoflurane is a prescription general anesthetic used to put patients asleep before surgery.

 Jolynn Tumolo

Back to Top